Morgan Stanley Reiterates Overweight Rating on Eli Lilly and Company (LLY)
Rating Change Morgan Stanley analysts reiterated a Overweight rating on Eli Lilly and Company (NYSE:LLY) on July 08, 2026. Market Context Eli Lilly and Company operates in the…
Read more
